| 中文名 | (3R,8S,10S,13S,14S,Z)-17-亚乙基-10 |
|---|---|
| 英文名 | (3R,5R,8S,10S,13S,14S,Z)-17-ethylidene-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
| 中文别名 |
脱氧胆酸杂质19
(3α,5β,17Z)-孕甾-9,17-二烯-3-醇 (3R,8S,10S,13S,14S,Z)-17-亚乙基-10,13-二甲基-2,3,4,5,6,7,8,10,12,13,14,15,16,17-十四氢-1H-环戊二烯并[A]菲-3-醇 |
| 英文别名 |
(3R,5R,8S,10S,13S,14S,Z)-17-ethylidene-10
(3R,8S,10S,13S,14S,Z)-17-Ethylidene-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol (Z)-3α-hydroxy-5β-pregna-9,17-diene (3α,5β,17Z)- Pregna-9(11),17-dien-3-ol Deoxycholic acid Impurity 19 Pregna-9(11),17-dien-3-ol, (3α,5β,17Z) CholicAcidImpurity56 |
| 分子式 | C21H32O |
|---|---|
| 分子量 | 300.47800 |
| 精确质量 | 300.24500 |
| PSA | 20.23000 |
| LogP | 5.25640 |
|
~%
1093397-66-0 |
| 文献:KYTHERA BIOPHARMACEUTICALS, INC.; MORIARTY, Robert M.; PRASAD, Achampeta Rathan; REID, John Gregory; SWARINGEN Jr., Roy A. Patent: WO2011/75701 A2, 2011 ; |
|
~%
1093397-66-0 |
| 文献:KYTHERA BIOPHARMACEUTICALS, INC.; MORIARTY, Robert M.; PRASAD, Achampeta Rathan; REID, John Gregory; SWARINGEN Jr., Roy A. Patent: WO2011/75701 A2, 2011 ; |
| 上游产品 2 | |
|---|---|
| 下游产品 3 | |